Abeona Therapeutics Inc. (ABEO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.3100 |
| Open | 4.3500 |
| Bid | 4.2800 x 200 |
| Ask | 4.3300 x 100 |
| Day's range | 4.2200 - 4.3900 |
| 52-week range | 2.8300 - 9.0100 |
| Volume | |
| Avg. volume | 723,322 |
| Market cap | 176.688M |
| Beta (5Y monthly) | 1.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.5300 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.75 |
- GuruFocus.com
Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
Explore key financial outcomes and strategic updates from Abeona Therapeutics' first quarter earnings call.
- Thomson Reuters StreetEvents
Q1 2024 Abeona Therapeutics Inc Earnings Call
Q1 2024 Abeona Therapeutics Inc Earnings Call
GlobeNewswireAbeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, extending expected cash runway into 2026 CLEVELAND, May 15, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2024 and recent corporate progress. “We are grateful to our existing as well as new investors who have demonstrated their support through the recent financing, which has extended our cash runway into 2026, well beyon
© 2024 Yahoo. All rights reserved.